Seki, R., Ohta, A., Niwa, A., Sugimine, Y., Naito, H., Nakahata, T., & Saito, M. K. (2021). Correction: Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity. PLoS One.
Dyfyniad Arddull ChicagoSeki, Ryosuke, Akira Ohta, Akira Niwa, Yoshinori Sugimine, Haruna Naito, Tatsutoshi Nakahata, and Megumu K. Saito. "Correction: Induced Pluripotent Stem Cell-derived Monocytic Cell Lines From a NOMID Patient Serve As a Screening Platform for Modulating NLRP3 Inflammasome Activity." PLoS One 2021.
Dyfyniad MLASeki, Ryosuke, et al. "Correction: Induced Pluripotent Stem Cell-derived Monocytic Cell Lines From a NOMID Patient Serve As a Screening Platform for Modulating NLRP3 Inflammasome Activity." PLoS One 2021.